Contributing Writer

0 Years of Experience


MedTech Strategist, Market Pathways, and the Community Blog are pleased to feature thought leadership contributed by medical device industry executives, regulators, consultants, investors, clinical KOLs, and other experts from the global medtech community.

Articles from Contributing Writer:

Regulatory & Reimbursement

Facing the Challenges of Bringing Medtech to Germany

The NUB reimbursement pathway has been effective in bringing high-cost innovative medical technologies to the German market, but there are challenges. The CRA Life Sciences practice assesses the funding of medtech through NUBs and outlines the strengths and weaknesses of the NUB pathway. By Eva Marchese, Lorenzo D’Angelo, Anthony Barron, Oriol Viader-Llargués, and Lukas Ziegler, CRA.

Read Article